<DOC>
	<DOCNO>NCT02287779</DOCNO>
	<brief_summary>This study investigate safety tolerability daily dose regimen SHP626 overweight obese adult .</brief_summary>
	<brief_title>Safety Tolerability Study SHP626 Overweight Obese Adults</brief_title>
	<detailed_description />
	<mesh_term>Overweight</mesh_term>
	<mesh_term>Fatty Liver</mesh_term>
	<mesh_term>Non-alcoholic Fatty Liver Disease</mesh_term>
	<criteria>Males comply applicable contraceptive requirement female nonchildbearing potential No history active chronic disease allow study ( hypertension , hyperlipidemia gastroesophageal reflux disease ( GERD ) heartburn ) Has body mass index 2535 kg/m2 body weight great 140lbs ( assessed screening ) No history alcohol substance abuse , include use tobacco No substantial change eat habit exercise routine .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>